Arcus Biosciences (RCUS) EBT Margin (QoQ) (2017 - 2026)
Arcus Biosciences (RCUS) EBT Margin (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arcus Biosciences | 3.73 Bn | 2.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43,173.00 |
| Dec 31, 2025 | 19,802.00 |
| Mar 31, 2025 | -4,231.00 |
| Dec 31, 2024 | -16,603.00 |
| Sep 30, 2024 | 4,679.00 |
| Jun 30, 2024 | -23,570.00 |
| Mar 31, 2024 | 56,867.00 |
| Dec 31, 2023 | -35,580.00 |
| Sep 30, 2023 | 3,955.00 |
| Jun 30, 2023 | 5,683.00 |
| Mar 31, 2023 | -11,494.00 |
| Dec 31, 2022 | -9.00 |
| Sep 30, 2022 | 5,118.00 |
| Jun 30, 2022 | 12,407.00 |
| Mar 31, 2022 | -45,161.00 |
| Dec 31, 2021 | 90,357.00 |
| Sep 30, 2021 | -2,119.00 |
| Jun 30, 2021 | -3,569.00 |
| Mar 31, 2021 | -19,749.00 |
| Dec 31, 2020 | -57,262.00 |